Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reveal the Level of Anxiety in Patients With Crohn's Disease Receiving Adalimumab

NCT01428115 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.

NCT NCT01428115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01428115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reveal the Level of Anxiety in Patients With Crohn's Disease Receiving Adalimumab
Lead sponsor
AbbVie (prior sponsor, Abbott)
Phase
Observational
Overall status
Completed
Start date
December 31, 2011
Completion date
October 31, 2013
Enrollment
83 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, severe crohn's disease